Articles From: Western Alliance Bancorporation Announces Fourth Quarter 2014 Earnings Release Date, Conference Call and Webcast to Allegiant Reports December 2014 Traffic


2015/1/8
Western Alliance Bancorporation (NYSE: WAL) announced today that it plans to release its fourth quarter 2014 financial results after the market closes on Thursday, January 22, 2015.
Sign-up for Western Alliance Bancorporation Announces Fourth Quarter 2014 Earnings Release Date, Conference Call and Webcast investment picks
2015/1/8
VANCOUVER , Jan.
Sign-up for Westport WiNG™ Power System 2015 Ford Transit Van Receives EPA Certification investment picks
2015/1/8
NEW YORK, Jan.
Sign-up for WisdomTree Announces Change to ETF Family investment picks
2015/1/8
Zep Inc. (NYSE: ZEP), a leading consumable chemical packaged goods company that manufactures a wide variety of high-performance maintenance and cleaning chemicals, is pleased to announce that at its meeting today, the Board of Directors declared a 20% increase in the quarterly cash dividend from $0.05 per common share to $0.06 cents per common share.
Sign-up for Zep Inc. Increases Quarterly Dividend 20% to $0.06 Per Share investment picks
2015/1/8
http://www.marketwire.com/library/MwGo/2015/1/7/11G029861/Columbus_Gold_Corporation-876293025395.jpg VANCOUVER, BC--(Marketwired - January 08, 2015) - Columbus Gold Corporation (TSX VENTURE: CGT) (OTCQX: CBGDF) ("Columbus Gold") is pleased to announce the results of comprehensive metallurgical test work from Columbus Gold's 100 % controlled Montagne d'Or Gold Deposit, Paul Isnard Project, in French Guiana.
Sign-up for 95% Gold Recoveries From Metallurgical Tests at Columbus Gold's Montagne d'Or Gold Deposit, French Guiana investment picks
2015/1/7
http://media3.marketwire.com/logos/20130528-aab0528.jpg TORONTO, ONTARIO --
Sign-up for Aberdeen Files Information Circular Outlining Plan for Value Creation and Exposing Dissident Self-Interest investment picks
2015/1/7
Acacia Research Corporation (NASDAQ: ACTG) announced today that its CEO and President, Matthew Vella, will discuss Acacia's patent licensing business at the 17 th Annual Needham Growth Conference.
Sign-up for Acacia Research to Present at 17th Annual Needham Growth Conference January 14, 2015 investment picks
2015/1/7
TUCSON, Ariz., Jan.
Sign-up for Accelerate Diagnostics to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/7
Accenture (NYSE:ACN), working in collaboration with the Office of Executive Education at the MIT Sloan School of Management, is developing the Accenture Technology Executive Development Program.
Sign-up for Accenture Working with MIT’s Sloan School of Management to Enable the Next Generation of Technology Leaders investment picks
2015/1/7
Accenture (NYSE:ACN)’s Duck Creek property and casualty (P&C) insurance claims software received two XCelent Awards in Celent's newly published report titled "Claims System Vendors: North American P&C Insurance 2014 1 .” Of the 31 core claims solutions profiled, Accenture Duck Creek Claims took top honors in two areas: technology and service.
Sign-up for Accenture’s Duck Creek Claims Software Recognized by Celent with Two Industry Awards for Technology and Service investment picks
2015/1/7
Activision Blizzard, Inc. (Nasdaq: ATVI) intends to release its fourth quarter 2014 results after the close of the market on Thursday, February 5, 2015.
Sign-up for Activision Blizzard to Release Fourth Quarter 2014 Financial Results on February 5, 2015 investment picks
2015/1/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167851&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for ADP Small Business Report: Small Business Employment Increased by 106,000 Jobs in December investment picks
2015/1/7
TAIPEI , Jan.
Sign-up for Advanced Semiconductor Engineering, Inc. Announces Monthly Net Revenues investment picks
2015/1/7
PRINCETON, N.J., Jan.
Sign-up for Advaxis and the GOG Foundation, Inc. to Collaborate on Global Phase 3 Clinical Trial of ADXS-HPV in Cervical Cancer investment picks
2015/1/7
MONTVALE, N.J. , Jan.
Sign-up for AEP Industries Inc. Schedules Conference Call to Discuss Fiscal Year 2014 Financial Results investment picks
2015/1/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167875&ProfileId=051205&sourceType=1 CARMEL, IN --
Sign-up for AFC Names Senior Vice President of Operations investment picks
2015/1/7
HEIDELBERG, Germany, Jan.
Sign-up for Affimed Receives EUR 2.4 million ($3 million) Research Grant from German Government to Fund Trispecific Abs investment picks
2015/1/7
Agilysys, Inc. (Nasdaq:AGYS), a leading provider of innovative hospitality software solutions and services, today announced that it has attained Gold Certified Partner status in the Microsoft Partner Program, with a competency in the Independent Software Vendor (ISV)/Software Solutions category.
Sign-up for Agilysys Attains Gold Certified Status in Microsoft Partner Program investment picks
2015/1/7
First-ever CLIA-waived molecular flu test delivers lab-accurate results at the point of care in less than 15 minutes WALTHAM, Mass.
Sign-up for Alere Receives FDA CLIA Waiver for Alere™ i Influenza A & B Test investment picks
2015/1/7
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today reported results from its randomized, open-label, multicenter Phase 2 clinical trial to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in living-donor kidney transplant recipients requiring desensitization.
Sign-up for Alexion Provides Update on Phase 2 Clinical Trial with Eculizumab in Antibody Mediated Rejection (AMR) in Living-Donor Kidney Transplant Recipients investment picks
2015/1/7
By Russ Britt, MarketWatch Treatment designed to help kidney patients accept new organs Shares of Alexion Pharmaceuticals Inc. fell in after-hours trades after the drug maker said its plan to use its Soliris blood-clotting treatment to help kidney transplant patients accept their new organ didn't meet its goals in the second phase of testing.
Sign-up for Alexion tumbles on failed transplant drug trial investment picks
2015/1/7
Alkermes plc (NASDAQ: ALKS) today announced positive topline results from the 12-week, randomized, double-blind, active-controlled, dose-ranging stage of a phase 2 study of ALKS 3831, an investigational, novel, oral atypical antipsychotic drug candidate designed to be a broad-spectrum treatment for schizophrenia.
Sign-up for Alkermes Announces Positive Results of Phase 2 Clinical Trial of ALKS 3831 in Schizophrenia investment picks
2015/1/7
Alkermes Plc shares (ALKS) rose 5% in premarket trade Wednesday, after the company announced positive results from a Phase 2 clinical trial of a treatment for schizophrenia.
Sign-up for Alkermes shares up 5% on news of positive trial for schizophrenia drug investment picks
2015/1/7
Allegheny Technologies Incorporated (NYSE: ATI) will provide live Internet listening access to its conference call with investors and analysts scheduled for Tuesday, January 20, 2015 at 8:30 a.m. ET.
Sign-up for Allegheny Technologies Announces Webcast of Conference Call for Fourth Quarter and Full-Year 2014 Results investment picks
2015/1/7
http://www.marketwire.com/library/MwGo/2015/1/7/11G029844/convertedPNGlogo-1774249373.jpg LAS VEGAS, NV--(Marketwired - January 07, 2015) - Allegiant Travel Company (NASDAQ: ALGT) today reported preliminary passenger traffic results for December 2014.
Sign-up for Allegiant Reports December 2014 Traffic investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Western Alliance Bancorporation Announces Fourth Quarter 2014 Earnings Release Date, Conference Call and Webcast to Allegiant Reports December 2014 Traffic
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent